Risk factors and diagnostic markers of bacteremia in Stevens-Johnson syndrome and toxic epidermal necrolysis: A cohort study of 176 patients

被引:26
|
作者
Koh, Hui Kai [1 ]
Chai, Zi Teng [2 ]
Tay, Hui Wen [1 ]
Fook-Chong, Stephanie [3 ]
Choo, Karen J. L. [2 ]
Oh, Choon Chiat [2 ]
Yeo, Yi Wei [2 ]
Koh, Hong Yi [2 ]
Pang, Shiu Ming [2 ]
Lee, Haur Yueh [2 ]
机构
[1] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore
[2] Singapore Gen Hosp, Dept Dermatol, Outram Rd, Singapore 169608, Singapore
[3] Singapore Gen Hosp, Hlth Serv Res Unit, Div Med, Singapore, Singapore
关键词
adverse drug reactions; bacteremia; diagnostic markers; microbiology; risk factors; sepsis; Stevens-Johnson syndrome; toxic epidermal necrolysis; RETROSPECTIVE ANALYSIS; UNKNOWN ORIGIN; PROCALCITONIN; EPIDEMIOLOGY; MULTIFORME; GUIDELINES; MANAGEMENT; FEVER;
D O I
10.1016/j.jaad.2019.05.096
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Sepsis is the main cause of death in Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Objectives: Our aim was to identify admission risk factors predictive of bacteremia and the accompanying clinical or biochemical markers associated with positive blood cultures. Methods: A retrospective cohort study over a 14-year period (2003-2016) was performed. Results: The study included 176 patients with SJS (n = 59), SJS-TEN overlap (n = 51), and TEN (n = 66). During hospitalization, bacteremia developed in 52 patients (29.5%), who experienced poorer outcomes, including higher intensive care unit admission (P < .0005), longer length of stay (P < .0005), and higher mortality (P < .0005). There were 112 episodes of bacteremia, and isolates included Acinetobacter baumannii (27.7%, n = 31) and Staphylococcus aureus (21.4%, n = 24). On multivariate analysis, clinical factors present at admission that were predictive of bacteremia included hemoglobin <= 10 g/dL (odds ratio [OR] 2.4, confidence interval [CI] 2.2-2.6), existing cardiovascular disease (OR 2.10, CI 2.0-2.3), and body surface area involvement >= 10% (OR 14.3, CI 13.4-15.2). The Bacteremia Risk Score was constructed with good calibration. Hypothermia (P = .03) and procalcitonin >= 1 mu g/L (P = .02) concurrent with blood culture sampling were predictive of blood culture positivity. Limitations: This is a retrospective study performed in a reference center. Conclusion: Hemoglobin <= 10 g/dL, cardiovascular disease, and body surface area involvement >= 10% on admission were risk factors for bacteremia. Hypothermia and elevated procalcitonin are useful markers for the timely detection of bacteremia.
引用
收藏
页码:686 / 693
页数:8
相关论文
共 50 条
  • [31] Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention
    Shanbhag, Swapna S.
    Koduri, Madhuri A.
    Kannabiran, Chitra
    Donthineni, Pragnya R.
    Singh, Vivek
    Basu, Sayan
    FRONTIERS IN GENETICS, 2021, 11
  • [32] Infectious complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and meta-analysis
    Stewart, Thomas Jonathan
    Chan, Chon-Wai Jeremy
    Shah, Hemali
    Frew, John
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2024, : 830 - 848
  • [33] Recurrence and Outcomes of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Children
    Finkelstein, Yaron
    Soon, Gordon S.
    Acuna, Patrick
    George, Mathew
    Pope, Elena
    Ito, Shinya
    Shear, Neil H.
    Koren, Gideon
    Shannon, Michael W.
    Garcia-Bournissen, Facundo
    PEDIATRICS, 2011, 128 (04) : 723 - 728
  • [34] Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: a Review and Update
    Coias, Jennifer L.
    Abbas, Laila F.
    Cardones, Adela R.
    CURRENT DERMATOLOGY REPORTS, 2019, 8 (04) : 219 - 233
  • [35] Stevens-Johnson syndrome/toxic epidermal necrolysis presumably induced by norfloxacin
    Maciejewska, Jolanta
    Jankowski, Marek
    Zegarska, Barbara
    Czajkowski, Rafal
    POSTEPY DERMATOLOGII I ALERGOLOGII, 2014, 31 (03): : 194 - 196
  • [36] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the Pediatric Population A Review
    Alerhand, Stephen
    Cassella, Courtney
    Koyfman, Alex
    PEDIATRIC EMERGENCY CARE, 2016, 32 (07) : 472 - 476
  • [37] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Review of Diagnosis and Management
    Frantz, Robert
    Huang, Simo
    Are, Abhirup
    Motaparthi, Kiran
    MEDICINA-LITHUANIA, 2021, 57 (09):
  • [38] Clinical Features, Risk Factors, and Prognostic Markers of Drug-Induced Liver Injury in Patients with Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
    Zhang, Zhibin
    Li, Sisi
    Zhang, Zhixiong
    Yu, Kaihui
    Duan, Xunxin
    Long, Lin
    Zhang, Shulan
    Jiang, Meiying
    Liu, Ougen
    INDIAN JOURNAL OF DERMATOLOGY, 2020, 65 (04) : 274 - 278
  • [39] A SYSTEM FOR THE RISK ASSESSMENT OF STEVENS-JOHNSON SYNDROME AND TOXIC EPIDERMAL NECROLYSIS APPEARANCE
    Zimenkovsky, A.
    Gorodnycha, O.
    PHARMACIA, 2013, 60 (04) : 31 - 36
  • [40] Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Evaluation
    Dicle, Oezlem
    Yilmaz, Ertan
    Alpsoy, Erkan
    TURKDERM-TURKISH ARCHIVES OF DERMATOLOGY AND VENEROLOGY, 2009, 43 (01): : 15 - 20